Pure Global
NCT06371001

Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex

Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical
Assiut University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Kidney Diseases
Drug/Device/Intervention
disease
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Jul 01, 2025
Enrollment
122 participants
Primary outcome

Helicobacter pylori infection and Chronic kidney diseased patient

Summary

Detect prevalence of Helicobacter pylori infection in chronic kidney diseased patient
 admitted to Luxor medical complex and possible role of Helicobacter pylori in pathogenesis of
 chronic kidney diseased patient of unknown etiology

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06371001
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06371001 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases. Target enrollment is 122 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.